CVS Health (NYSE:CVS) had its price target raised by analysts at TD Cowen from $100.00 to $105.00. They now have a "buy" rating on the stock.
CVS Health (NYSE:CVS) was given a new $87.00 price target on by analysts at Sanford C. Bernstein.
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak [Yahoo! Finance]
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
CVS Health (NYSE:CVS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $93.00 to $95.00. They now have a "buy" rating on the stock.